Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1093569
Max Phase: Preclinical
Molecular Formula: C21H19BrN2O3
Molecular Weight: 427.30
Molecule Type: Small molecule
Associated Items:
ID: ALA1093569
Max Phase: Preclinical
Molecular Formula: C21H19BrN2O3
Molecular Weight: 427.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(CNC(=O)c1cc(Br)ccc1O)/N=C/c1c(O)ccc2ccccc12
Standard InChI: InChI=1S/C21H19BrN2O3/c1-13(11-24-21(27)17-10-15(22)7-9-19(17)25)23-12-18-16-5-3-2-4-14(16)6-8-20(18)26/h2-10,12-13,25-26H,11H2,1H3,(H,24,27)/b23-12+
Standard InChI Key: MQGPNPQECRYIHR-FSJBWODESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 427.30 | Molecular Weight (Monoisotopic): 426.0579 | AlogP: 4.25 | #Rotatable Bonds: 5 |
Polar Surface Area: 81.92 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.71 | CX Basic pKa: 5.00 | CX LogP: 5.02 | CX LogD: 4.84 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.53 | Np Likeness Score: -0.64 |
1. Cheng K, Zheng QZ, Hou J, Zhou Y, Liu CH, Zhao J, Zhu HL.. (2010) Synthesis, molecular modeling and biological evaluation of PSB as targeted antibiotics., 18 (7): [PMID:20304657] [10.1016/j.bmc.2010.02.052] |
Source(1):